Skip to main content

A cure for lung cancer? Breakthrough treatment possible new mainstay against lung cancer

Immunotherapy drug outperforms chemo in latest trial

A recent study comparing the immunotherapy drug pembrolizumab to chemotherapy could alter more than 30 years of practice in lung cancer treatment.

The clinical trial, known as Keynote-024 (KN-024), showed pembrolizumab’s superiority in preventing cancer progression and prolonging the lives of previously untreated patients with non-small cell lung cancer (NSCLC).

“We believe that the KEYNOTE-024 results have the potential to change the therapeutic paradigm in first-line treatment of non-small cell lung cancer,” said Dr. Roger M. Perlmutter, president of MSD Research Laboratories. “We look forward to sharing these data with the medical community and with regulatory authorities around the world.”

Pembrolizumab boosts the immune system’s antitumor activity by preventing cancer cells from interacting with the immune system’s T-cells. During interaction, tumor cells produce a protein called the Programmed Death-Ligand 1 (PD-L1) which deactivates T-cells. Blocking this enables T-cells to remain capable of detecting and destroying cancer in the body.

The Philippine Food and Drug Administration (FDA) approved pembrolizumab for the treatment of advanced melanoma and PD-L1-positive lung cancer that failed previous therapies. Immuno-oncology leader MSD introduced this breakthrough anti-cancer drug in the Philippines last March.

Consistent results on safety and efficacy

KN-024 is a randomized study with 305 participants who received either pembrolizumab or chemotherapy. When it demonstrated the new drug’s efficacy in halting the progress of cancer and increasing survival rates, an independent Data Monitoring Committee (DMC) recommended an end to the trial. The DMC further recommended that patients on chemotherapy be given the opportunity to receive pembrolizumab.

The results also showed that the drug was consistent in terms of safety and tolerability, with side effects commonly immune-mediated, or due to the response of the immune system. Only less than five percent of participants experienced these adverse effects during the study.
In case of a severe reaction to the drug, doctors advise stopping treatment temporarily and taking steroids to alleviate the side effects. Treatment may resume once the patient’s condition improves.

A game-changer in cancer treatment

According to Globocan 2012, lung cancer is the top cause of cancer mortality worldwide, accounting for 1.5 million deaths annually. In the Philippines, doctors report over 12,000 new cases of lung cancer each year and more 10,000 deaths due to the disease.

With immunotherapy possibly becoming the new standard of lung cancer treatment, millions of patients can now hope for better chances of survival while being spared from the harsh effects of existing treatment options.

MSD will present the results of the KN-024 trial in an upcoming medical meeting.


Popular posts from this blog

Dina dela Paz, Awarded as Most Influential Filipina in the World

Another Filipina awarded in the 100 MOST INFLUENTIAL FILIPINA IN THE WORLD.
Dina Dela Paz-Stalder, a skincare expert, was awarded with this prestigious recognition, specifically in the Founder and Pioneer Category (Global FWN100 Award) in Toronto, Canada on October 27, 2017, by Filipino Women’s Network. She was selected from an outstanding field of nominees from around the world.

The Global FWN100 Award™ recognizes 100 Filipino women who are changing the face of leadership in the global workplace.  It distinguishes them for their outstanding work in their respective fields, and further recognizes them for their achievement and contributions to society.  Dina Dela Paz-Stalder’s award and global recognition is another evidence of Filipino pride as she proves that Filipinos are also global leaders in terms of skincare innovations and extraordinary leadership.

Started from just a small steel pot for skincare formulations,  she now owns and leads the Stalder Group of Companies which includ…

City Garden Grand Hotel Holds 2nd GRAND Skills Competition

Today, students from the Far Eastern University, National University, Philippine Women University, Lyceum and the University of Sto. Tomas got together for City Garden Grand Hotel’s 2nd GRAND Skills Competition.

For the second time City Garden Grand Hotel hold the competition where the top 5 schools competed for the chance to be the best in the following categories: Table set up with Centerpieces, Food Art, Bartending/Cocktail Mixing, and Gourmet Student Meals.

For six hours, students took the time to set up tables with their own theme and menu, prepared gourmet meals, food art and concoct drinks. Then it was time for the judges to pick the best among the best. Judges includes Chef Miko Aspiras, Jill Meneses, Chef Dennis Peralta, Jason Hussein Ali, Jordan Tan.

Here is the list of winners for the following categories:

1st Place:Far Eastern University (FEU) 2nd Place:LYCEUM 3rd Place:National University (NU)
1st Place:LYCEUM 2nd Place:NU 3rd Place:University of Sto. …

POSIBLE.NET officially launched as it empowers Filipino MSMEs with greater possibilities

Thinking of a lucrative investment? Nope, this is not a get-rich-quick scheme but something you can depend on for many years to come. As we live in the digital world, we’re looking for ease and comfort while we do our daily transactions. Time is gold for everyone, and so does for our customers who want things fast and not bothersome. Introducing POSIBLE.NET, the latest aggregator of digital services that caters both to clients and those into small businesses.

Last January 24, 2018 POSIBLE.NET was officially launched at Holiday Inn and Suites, Makati City. With over 1,600 retailers nationwide to date, POSIBLE.NET targets to become the dominant community-based digital transactions network in the country and looked forward to a year full of possibilities, going with the theme “Empowering the Filipino MSMEs of Today.”

POSIBLE.NET, founded two years ago, currently offers more than 300 digital services to over a million Filipino consumers and has already generated close to P2 billion worth o…